Michael F. Huang is Sr. VP of Clinical Development of SOLENO THERAPEUTICS INC. Currently has a direct ownership of 35,000 shares of SLNO, which is worth approximately $1.68 Million. The most recent transaction as insider was on Jul 17, 2024, when has been sold 35,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 35K
0% 3M change
n/a 12M change
Total Value Held $1.68 Million

Michael F. Huang Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 17 2024
BUY
Grant, award, or other acquisition
-
35,000 Added 50.0%
35,000 Common Stock
MFH

Michael F. Huang

Sr. VP of Clinical Development
Redwood City, CA

Track Institutional and Insider Activities on SLNO

Follow SOLENO THERAPEUTICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SLNO shares.

Notify only if

Insider Trading

Get notified when an Soleno Therapeutics Inc insider buys or sells SLNO shares.

Notify only if

News

Receive news related to SOLENO THERAPEUTICS INC

Track Activities on SLNO